LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

LLY

1,036.37

-0.35%↓

JNJ

243.49

+0.08%↑

ABBV

232.69

+0.55%↑

NVS

166.17

+2.06%↑

MRK

121.6

+0.22%↑

Home・Akcijų sąrašas・MiNK Therapeutics

MiNK Therapeutics

Uždarymo kaina

11 -0.45

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

10.59

Max

Pagrindiniai rodikliai
By Trading Economics
Pajamos	1.4M -2.9M
Pelnas, tenkantis vienai akcijai	-0.65
Darbuotojai	23
EBITDA	1.3M -2.8M

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-10M 52M
Ankstesnė atidarymo kaina	11.45
Ankstesnė uždarymo kaina	11

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Bullish Evidence

7.81 / 8.1 Palaikymas ir pasipriešinimas

MiNK Therapeutics Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-17 23:44; UTC

Karštos akcijos

Stocks to Watch: La-Z-Boy, Palo Alto Networks, Caesars

2026-02-17 23:20; UTC

Uždarbis

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps -- Update

2026-02-17 22:57; UTC

Uždarbis

Santos Fiscal Year Net Profit Falls 33%, Nears Start of Alaska Project

2026-02-17 21:59; UTC

Uždarbis

Palo Alto Networks Lifts FY26 Revenue Outlook as 2Q Profit Jumps

2026-02-17 23:54; UTC

Rinkos pokalbiai

Nikkei May Rise as Fears About AI Disruption Ease -- Market Talk

2026-02-17 23:54; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-02-17 23:54; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-02-17 23:45; UTC

Rinkos pokalbiai

Suncorp's Outperformance of IAG Could Be Hard to Sustain -- Market Talk

2026-02-17 23:19; UTC

Uždarbis

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

2026-02-17 23:15; UTC

Uždarbis

Palo Alto's Guidance Overshadows Strong Earnings. Its Stock Is Down. -- Barrons.com

2026-02-17 22:58; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Netflix Would Operate Warner's Studios, HBO Largely the Same -- Market Talk

2026-02-17 22:58; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Steel: Board Committed to Optimizing Value For Shareholders

2026-02-17 22:57; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope Steel to Consider Revised SGH, Steel Dynamics Takeover Bid

2026-02-17 22:50; UTC

Įsigijimai, susijungimai, perėmimai

Agnico-Eagle Mines Acquired 662,780 Common Shrs of Maple Gold Mines at C$2.45 Per Common Shr >AEM.T

2026-02-17 22:44; UTC

Uždarbis

Palo Alto Reports Strong Earnings. Its Stock Is Down. -- Barrons.com

2026-02-17 22:42; UTC

Uždarbis

Santos FY Net Profit Falls 33%, Nears Start of Alaska Project

2026-02-17 22:36; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Netflix Sarandos: Paramount Causing Confusion Around Warner Deal -- Market Talk

2026-02-17 22:36; UTC

Uždarbis

Santos Final Dividend 10.3 U.S. Cents/Security

2026-02-17 22:36; UTC

Uždarbis

Santos FY Underlying Profit US$898 Million, Down 25%

2026-02-17 22:35; UTC

Uždarbis

Santos FY Revenue US$4.94 Billion, Down 8%

2026-02-17 22:35; UTC

Uždarbis

Correct: Santos FY Net Profit US$818 Million, Down 33%

2026-02-17 22:35; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Buys New York Times Stock; Sells Apple, Bank of America, Amazon In 4Q -- Barrons.com

2026-02-17 22:34; UTC

Uždarbis

Santos FY Net Profit US$818 Billion, Down 33%

2026-02-17 22:02; UTC

Įsigijimai, susijungimai, perėmimai

Berkshire Pares Stakes in Apple and BofA, Adds New York Times Position -- Update

2026-02-17 21:50; UTC

Įsigijimai, susijungimai, perėmimai

Steel Dynamics: SGH Would Buy BlueScope, On-sell North American Operations to SDI, As Earlier Proposed

2026-02-17 21:50; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2026-02-17 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-17 21:49; UTC

Įsigijimai, susijungimai, perėmimai

Steel Dynamics Says Revised Proposal Continues to Present Highly Strategic Opportunity For SDI Shareholders

2026-02-17 21:48; UTC

Įsigijimai, susijungimai, perėmimai

Steel Dynamics: BlueScope Offer a 56% Premium to 52-Week Volume Weighted Average Price

2026-02-17 21:48; UTC

Įsigijimai, susijungimai, perėmimai

Steel Dynamics: Consideration To Be Comprised Entirely of Cash

Akcijų palyginimas

Kainos pokytis

MiNK Therapeutics Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

Pirkti

Laikyti

Parduoti

Remiantis 0 analitikų, pateikusių MiNK Therapeutics akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

7.81 / 8.1Palaikymas ir pasipriešinimas

Recent bullish events outweigh bearish events.

There is one bearish event.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Kitos sektoriaus akcijos

LLY

Eli Lilly and Co.

1,036.37

↓-0.35%

JNJ

Johnson and Johnson

243.49

↑ +0.08%

ABBV

AbbVie Inc

232.69

↑ +0.55%

NVS

Novartis AG

166.17

↑ +2.06%

MRK

Merck & Co Inc.

121.6

↑ +0.22%

MiNK Therapeutics

Apžvalga

Akcijų kainos pasikeitimas

Pagrindiniai rodikliai

Rinkos statistika

Techninis įvertinimas

MiNK Therapeutics Grafikas

Susijusios naujienos

Akcijų palyginimas

MiNK Therapeutics Prognozė

Bendras įvertinimas

Techninis įvertinimas

Finansinės naujienos

Kitos sektoriaus akcijos